Works by Vives, Susana


Results: 40
    1

    A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 7, p. 2317, doi. 10.1002/cam4.2814
    By:
    • Ribera, Josep‐Maria;
    • Morgades, Mireia;
    • Montesinos, Pau;
    • Tormo, Mar;
    • Martínez‐Carballeira, Daniel;
    • González‐Campos, José;
    • Gil, Cristina;
    • Barba, Pere;
    • García‐Boyero, Raimundo;
    • Coll, Rosa;
    • Pedreño, María;
    • Ribera, Jordi;
    • Mercadal, Santiago;
    • Vives, Susana;
    • Novo, Andrés;
    • Genescà, Eulàlia;
    • Hernández‐Rivas, Jesús‐María;
    • Bergua, Juan;
    • Amigo, María‐Luz;
    • Vall‐Llovera, Ferran
    Publication type:
    Article
    2

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    3

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    4

    A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 4, p. 1, doi. 10.1038/s41408-020-0308-3
    By:
    • Sánchez, Ricardo;
    • Ribera, Jordi;
    • Morgades, Mireia;
    • Ayala, Rosa;
    • Onecha, Esther;
    • Ruiz-Heredia, Yanira;
    • Juárez-Rufián, Alexandra;
    • de Nicolás, Rodrigo;
    • Sánchez-Pina, José;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Mercadal, Santiago;
    • Coll, Rosa;
    • Cervera, Marta;
    • García, Olga;
    • Ribera, Josep-Maria;
    • Martínez-López, Joaquín
    Publication type:
    Article
    5

    P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3‐ITD MUTATED AML.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969032.40255.74
    By:
    • Tormo, Mar;
    • Diaz‐Beya, Marina;
    • Beneit, Paola;
    • Fernández Moreno, Ainhoa;
    • Arnan, Montserrat;
    • Garrido Diaz, Ana;
    • Vives, Susana;
    • García Fortes, Maria;
    • Sampol, Antonia;
    • Labrador, Jorge;
    • Garcia‐Guiñon, Antonio;
    • Botella, Carmen;
    • Miguel Bergua Burgues, Juan;
    • Olave, Mayte;
    • Luz Amigo, Maria;
    • Ortín, Xavier;
    • Ferran Vall‐Llovera, Ferrand;
    • Pereiro, Maria;
    • Serrano, Josefina;
    • Jose Sayas Lloris, Maria
    Publication type:
    Article
    6

    P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000968868.83152.da
    By:
    • Döhner, Hartmut;
    • Montesinos, Pau;
    • Vives Polo, Susana;
    • Zarzycka, Ewa;
    • Wang, Jianxiang;
    • Riva, Marta;
    • Heuser, Michael;
    • Calado, Rodrigo;
    • Schuh, Andre;
    • Yeh, Su‐Peng;
    • Hui, Jianan;
    • Gianolio, Diego;
    • A Patel, Prapti;
    • Recher, Christian;
    • de Botton, Stephane
    Publication type:
    Article
    7

    P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE.

    Published in:
    2023
    By:
    • Sobas, Marta;
    • Knopinska-Posluszny, Wanda;
    • Piątkowska-Jakubas, Beata;
    • Ossenkoppele, Gert;
    • García-Álvarez, Flor;
    • Elena Amutio Díez, María;
    • Caballero, Mar;
    • Martinez-Cuadrón, David;
    • Aguiar, Eliana;
    • Gonzalez Campos, Jose;
    • Garrido Diaz, Ana;
    • Algarra, Lorenzo;
    • Salamero, Olga;
    • de la Serna, Javier;
    • Jose Sayas Lloris, Maria;
    • Mateo Perez Encinas, Manuel;
    • Vives Polo, Susana;
    • Gonzalez DE LA Calle, Veronica;
    • Labrador, Jorge;
    • Inés Prado, Ana
    Publication type:
    Abstract
    8

    S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML.

    Published in:
    2023
    By:
    • Montesinos, Pau;
    • Rodríguez-Veiga, Rebeca;
    • Bergua Burgues, Juan Miguel;
    • Algarra, Lorenzo;
    • Botella, Carmen;
    • Josè Antonio, Perez Simon;
    • Bernal, Teresa;
    • Tormo, Mar;
    • Robles, Maria Calbacho;
    • Salamero, Olga;
    • Serrano, Josefina;
    • Noriega, Victor;
    • López-López, Juan Antonio;
    • Polo, Susana Vives;
    • Colorado, Mercedes;
    • Lorenzo, Jose Luis Lopez;
    • Vidriales, María Belén;
    • Boyero, Raimundo Garcia;
    • Olave, Mayte;
    • Herrera-Puente, Pilar
    Publication type:
    Abstract
    9

    A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 13, p. 3192, doi. 10.1080/10428194.2021.1950706
    By:
    • Sweet, Kendra;
    • Bhatnagar, Bhavana;
    • Döhner, Hartmut;
    • Donnellan, Will;
    • Frankfurt, Olga;
    • Heuser, Michael;
    • Kota, Vamsi;
    • Liu, Hongtao;
    • Raffoux, Emmanuel;
    • Roboz, Gail J.;
    • Röllig, Christoph;
    • Showel, Margaret M.;
    • Strickland Jr., Stephen A.;
    • Vives, Susana;
    • Tang, Shijie;
    • Unger, Thaddeus J.;
    • Joshi, Anita;
    • Shen, Yao;
    • Alvarez, Mariano J.;
    • Califano, Andrea
    Publication type:
    Article
    10

    Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 12, p. 2928, doi. 10.1080/10428194.2021.1948031
    By:
    • Palanques-Pastor, Tomás;
    • Megías-Vericat, Juan Eduardo;
    • Martínez, Pilar;
    • López Lorenzo, José Luis;
    • Cornago Navascués, Javier;
    • Rodriguez Macias, Gabriela;
    • Cano, Isabel;
    • Arnan Sangerman, Montserrat;
    • Vidriales Vicente, María Belén;
    • Algarra Algarra, Jesús Lorenzo;
    • Foncillas, María Ángeles;
    • Herrera, Pilar;
    • Botella Prieto, Carmen;
    • Vives, Susana;
    • Figuera Álvarez, Ángela;
    • Cuevas Palomares, Laida;
    • Sobas, Marta;
    • Contento Gonzalo, Alejandro;
    • Cuello García, Rebeca;
    • Amutio Diez, María Elena
    Publication type:
    Article
    11

    Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2720, doi. 10.1080/10428194.2019.1607327
    By:
    • Salamero, Olga;
    • Martínez-Cuadrón, David;
    • Sobas, Marta;
    • Benavente, Celina;
    • Vives, Susana;
    • De la Serna, Javier;
    • Pérez-Encinas, Manuel;
    • Escoda, Lourdes;
    • Gil, Cristina;
    • Brunet, Salut;
    • Ramos, Fernando;
    • Esteve, Jordi;
    • Amigo, Mariluz;
    • Krsnik, Isabel;
    • Manso, Félix;
    • Arias, Jesús;
    • González-Campos, José;
    • Serrano, Josefina;
    • Oleksiuk, Jalanta;
    • Barrios, Manuel
    Publication type:
    Article
    12

    Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 7, p. 1634, doi. 10.1080/10428194.2017.1397661
    By:
    • Ribera, Josep-Maria;
    • Morgades, Mireia;
    • Montesinos, Pau;
    • Martino, Rodrigo;
    • Barba, Pere;
    • Soria, Beatriz;
    • Bermúdez, Arancha;
    • Moreno, María-José;
    • González-Campos, José;
    • Vives, Susana;
    • Gil, Cristina;
    • Abella, Eugenia;
    • Guàrdia, Ramon;
    • Martínez-Carballeira, Daniel;
    • Martínez-Sánchez, Pilar;
    • Amigo, María-Luz;
    • Mercadal, Santiago;
    • Serrano, Alfons;
    • López-Martínez, Aurelio;
    • Vall-Llovera, Ferran
    Publication type:
    Article
    13

    Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 4, p. 916, doi. 10.1080/10428194.2016.1222378
    By:
    • Sorigue, Marc;
    • Sancho, Juan-Manuel;
    • Morgades, Mireia;
    • Moreno, Miriam;
    • Grífols, Juan-Ramon;
    • Alonso, Eva;
    • Juncà, Jordi;
    • Ferrà, Christelle;
    • Batlle, Montserrat;
    • Vives, Susana;
    • Motlló, Cristina;
    • García-Caro, Montserrat;
    • Navarro, Jose-Tomás;
    • Millà, Fuensanta;
    • Feliu, Evarist;
    • Ribera, Josep-María
    Publication type:
    Article
    14
    15
    16

    A phase 2, multicenter, clinical trial of CPX‐351 in older patients with secondary or high‐risk acute myeloid leukemia: PETHEMA‐LAMVYX.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35618
    By:
    • Rodríguez‐Arbolí, Eduardo;
    • Rodríguez‐Veiga, Rebeca;
    • Soria‐Saldise, Elena;
    • Bergua, Juan M.;
    • Caballero‐Velázquez, Teresa;
    • Arnán, Montserrat;
    • Vives, Susana;
    • Serrano, Josefina;
    • Bernal, Teresa;
    • Martínez‐Sánchez, Pilar;
    • Tormo, Mar;
    • Rodríguez‐Medina, Carlos;
    • Herrera‐Puente, Pilar;
    • Lavilla‐Rubira, Esperanza;
    • Boluda, Blanca;
    • Acuña‐Cruz, Evelyn;
    • Cano, Isabel;
    • Cáceres, Sara;
    • Ballesteros, Juan;
    • Falantes, José
    Publication type:
    Article
    17

    Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 2, p. 451, doi. 10.1007/s00277-023-05582-y
    By:
    • Sobas, Marta;
    • Knopinska-Posluszny, Wanda;
    • Piątkowska-Jakubas, Beata;
    • García-Álvarez, Flor;
    • Díez, María Elena Amutio;
    • Caballero, Mar;
    • Martínez-Cuadrón, David;
    • Aguiar, Eliana;
    • González-Campos, Jose;
    • Garrido, Ana;
    • Algarra, Lorenzo;
    • Salamero, Olga;
    • de la Serna, Javier;
    • Sayas, Maria Jose;
    • Perez-Encinas, Manuel Mateo;
    • Vives, Susana;
    • Vidriales, Belén;
    • Labrador, Jorge;
    • Prado, Ana Inés;
    • Celebrin, Lucía
    Publication type:
    Article
    18

    A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.

    Published in:
    2021
    By:
    • Martínez Sánchez, María P.;
    • Megías-Vericat, Juan Eduardo;
    • Rodríguez-Veiga, Rebeca;
    • Vives, Susana;
    • Bergua, Juan Miguel;
    • Torrent, Anna;
    • Suárez-Varela, Sara;
    • Boluda, Blanca;
    • Martínez-López, Joaquín;
    • Cano-Ferri, Isabel;
    • Acuña-Cruz, Evelyn;
    • Torres-Miñana, Laura;
    • Martín-Herreros, Beatriz;
    • Serrano, Alfons;
    • Sempere, Amparo;
    • Barragán, Eva;
    • Sargas, Claudia;
    • Sanz, Miguel;
    • Martínez-Cuadrón, David;
    • Montesinos, Pau
    Publication type:
    journal article
    19

    Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • on behalf of the CETLAM and PETHEMA groups;
    • CETLAM and PETHEMA groups;
    • Boluda, Blanca;
    • Rodríguez-Veiga, Rebeca;
    • Moscardó, Federico;
    • Martínez-Cuadrón, David;
    • Cordón, Lourdes;
    • Sempere, Amparo;
    • Montesinos, Pau;
    • Sanz, Miguel A.;
    • Garrido, Ana;
    • Benavente, Celina;
    • Pérez-Simón, José Antonio;
    • Martínez, Pilar;
    • Jiménez-Ubieto, Ana;
    • Bergua, Juan;
    • Prieto-Delgado, Julio;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina;
    • Vives, Susana
    Publication type:
    journal article
    20

    A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • on behalf of the CETLAM and PETHEMA groups;
    • CETLAM and PETHEMA groups;
    • Boluda, Blanca;
    • Rodríguez-Veiga, Rebeca;
    • Moscardó, Federico;
    • Martínez-Cuadrón, David;
    • Cordón, Lourdes;
    • Sempere, Amparo;
    • Montesinos, Pau;
    • Sanz, Miguel A.;
    • Garrido, Ana;
    • Benavente, Celina;
    • Pérez-Simón, José Antonio;
    • Martínez, Pilar;
    • Jiménez-Ubieto, Ana;
    • Bergua, Juan;
    • Prieto-Delgado, Julio;
    • Esteve, Jordi;
    • Díaz-Beyá, Marina;
    • Vives, Susana
    Publication type:
    journal article
    21

    The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054458
    By:
    • Villar, Sara;
    • Ariceta, Beñat;
    • Agirre, Xabier;
    • Urribarri, Aura Daniela;
    • Ayala, Rosa;
    • Martínez-Cuadrón, David;
    • Bergua, Juan Miguel;
    • Vives, Susana;
    • Algarra, Lorenzo;
    • Tormo, Mar;
    • Martínez, Pilar;
    • Serrano, Josefina;
    • Simoes, Catia;
    • Herrera, Pilar;
    • Calasanz, Maria José;
    • Alfonso-Piérola, Ana;
    • Paiva, Bruno;
    • Martínez-López, Joaquín;
    • San Miguel, Jesús F.;
    • Prósper, Felipe
    Publication type:
    Article
    22

    A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
    By:
    • Vives, Susana;
    • Martínez‐Cuadrón, David;
    • Bergua Burgues, Juan;
    • Algarra, Lorenzo;
    • Tormo, Mar;
    • Martínez‐Sánchez, María Pilar;
    • Serrano, Josefina;
    • Herrera, Pilar;
    • Ramos, Fernando;
    • Salamero, Olga;
    • Lavilla, Esperanza;
    • López‐Lorenzo, José L.;
    • Gil, Cristina;
    • Vidriales, Belén;
    • Falantes, Jose F.;
    • Serrano, Alfons;
    • Labrador, Jorge;
    • Sayas, María J.;
    • Foncillas, María Á.;
    • Amador Barciela, María L.
    Publication type:
    Article
    23

    Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.

    Published in:
    2019
    By:
    • Ribera, Josep‐Maria;
    • García, Olga;
    • Moreno, María‐José;
    • Barba, Pere;
    • García‐Cadenas, Irene;
    • Mercadal, Santiago;
    • Montesinos, Pau;
    • Barrios, Manuel;
    • González‐Campos, José;
    • Martínez‐Carballeira, Daniel;
    • Gil, Cristina;
    • Ribera, Jordi;
    • Vives, Susana;
    • Novo, Andrés;
    • Cervera, Marta;
    • Serrano, Josefina;
    • Lavilla, Esperanza;
    • Abella, Eugenia;
    • Tormo, Mar;
    • Amigo, María‐Luz
    Publication type:
    journal article
    24

    Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 4028, doi. 10.3390/cancers16234028
    By:
    • Vives, Susana;
    • Quintela, David;
    • Morgades, Mireia;
    • Cano-Ferri, Isabel;
    • Serrano, Alfons;
    • Acuña-Cruz, Evelyn;
    • Cervera, Marta;
    • Díaz-Beyá, Marina;
    • Vidriales, Belén;
    • Raposo-Puglia, José Ángel;
    • Arnan, Montserrat;
    • Garrido, Ana;
    • Balerdi, Amaia;
    • Cabello, Ana Isabel;
    • Herrera-Puente, Pilar;
    • Serrano, Josefina;
    • Coll, Rosa;
    • Tormo, Mar;
    • López-Marín, Javier;
    • García-Ávila, Sara
    Publication type:
    Article
    25

    Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.

    Published in:
    Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092342
    By:
    • Labrador, Jorge;
    • Martínez-Cuadrón, David;
    • de la Fuente, Adolfo;
    • Rodríguez-Veiga, Rebeca;
    • Serrano, Josefina;
    • Tormo, Mar;
    • Rodriguez-Arboli, Eduardo;
    • Ramos, Fernando;
    • Bernal, Teresa;
    • López-Pavía, María;
    • Trigo, Fernanda;
    • Martínez-Sánchez, María Pilar;
    • Rodríguez-Gutiérrez, Juan-Ignacio;
    • Rodríguez-Medina, Carlos;
    • Gil, Cristina;
    • Belmonte, Daniel García;
    • Vives, Susana;
    • Foncillas, María-Ángeles;
    • Pérez-Encinas, Manuel;
    • Novo, Andrés
    Publication type:
    Article
    26

    Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1734, doi. 10.3390/cancers14071734
    By:
    • Labrador, Jorge;
    • Saiz-Rodríguez, Miriam;
    • de Miguel, Dunia;
    • de Laiglesia, Almudena;
    • Rodríguez-Medina, Carlos;
    • Vidriales, María Belén;
    • Pérez-Encinas, Manuel;
    • Sánchez-Sánchez, María José;
    • Cuello, Rebeca;
    • Roldán-Pérez, Alicia;
    • Vives, Susana;
    • Benzo-Callejo, Gonzalo;
    • Colorado, Mercedes;
    • García-Fortes, María;
    • Sayas, María José;
    • Olivier, Carmen;
    • Recio, Isabel;
    • Conde-Royo, Diego;
    • Bienert-García, Álvaro;
    • Vahi, María
    Publication type:
    Article
    27

    The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.

    Published in:
    Cancers, 2021, v. 13, n. 10, p. 2458, doi. 10.3390/cancers13102458
    By:
    • Ayala, Rosa;
    • Rapado, Inmaculada;
    • Onecha, Esther;
    • Martínez-Cuadrón, David;
    • Carreño-Tarragona, Gonzalo;
    • Bergua, Juan Miguel;
    • Vives, Susana;
    • Algarra, Jesus Lorenzo;
    • Tormo, Mar;
    • Martinez, Pilar;
    • Serrano, Josefina;
    • Herrera, Pilar;
    • Ramos, Fernando;
    • Salamero, Olga;
    • Lavilla, Esperanza;
    • Gil, Cristina;
    • López Lorenzo, Jose Luis;
    • Vidriales, María Belén;
    • Labrador, Jorge;
    • Falantes, José Francisco
    Publication type:
    Article
    28

    CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.

    Published in:
    Diagnostic Pathology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13000-025-01655-w
    By:
    • González-Guerrero, Laura;
    • Castellet, Helena;
    • Martínez, Clara;
    • González, Nuria;
    • Guijarro, Francesca;
    • Lloveras, Natalia;
    • Pratcorona, Marta;
    • Gich, Ignasi;
    • Berenguer-Molins, Pau;
    • Perera-Bel, Júlia;
    • Zamora, Lurdes;
    • Mascaró, Martí;
    • Sampol, Antonia;
    • Garcia-Guiñón, Antoni;
    • Vives, Susana;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Villamor, Neus;
    • Nomdedéu, Josep F.
    Publication type:
    Article
    29

    Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2023, v. 201, n. 6, p. 1239, doi. 10.1111/bjh.18815
    By:
    • Simoes, Catia;
    • Villar, Sara;
    • Ariceta, Beñat;
    • Garcés, Juan‐José;
    • Burgos, Leire;
    • Alignani, Diego;
    • Sarvide, Sarai;
    • Martínez‐Cuadrón, David;
    • Bergua, Juan‐Miguel;
    • Vives, Susana;
    • Algarra, Lorenzo;
    • Tormo, Mar;
    • Martinez, Pilar;
    • Serrano, Josefina;
    • Herrera, Pilar;
    • Ramos, Fernando;
    • Salamero, Olga;
    • Lavilla, Esperanza;
    • Gil, Cristina;
    • Lopez‐Lorenzo, Jose‐Luis
    Publication type:
    Article
    30

    Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
    By:
    • Bataller, Alex;
    • Oñate, Guadalupe;
    • Diaz‐Beyá, Marina;
    • Guijarro, Francesca;
    • Garrido, Ana;
    • Vives, Susana;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Salamero, Olga;
    • Sampol, Antònia;
    • Coll, Rosa;
    • Vall‐Llovera, Ferran;
    • Oliver‐Caldés, Aina;
    • López‐Guerra, Mònica;
    • Pratcorona, Marta;
    • Zamora, Lurdes;
    • Villamon, Eva;
    • Roué, Gaël;
    • Blanco, Adoración;
    • Nomdedeu, Josep F.
    Publication type:
    Article
    31

    The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 2, p. 263, doi. 10.1111/bjh.15887
    By:
    • Ribera, Jordi;
    • Granada, Isabel;
    • Morgades, Mireia;
    • Vives, Susana;
    • Genescà, Eulàlia;
    • González, Celia;
    • Nomdedeu, Josep;
    • Escoda, Lourdes;
    • Montesinos, Pau;
    • Mercadal, Santiago;
    • Coll, Rosa;
    • González‐Campos, José;
    • Abella, Eugenia;
    • Barba, Pere;
    • Bermúdez, Arancha;
    • Gil, Cristina;
    • Tormo, Mar;
    • Pedreño, María;
    • Martínez‐Carballeira, Daniel;
    • Hernández‐Rivas, Jesús‐María
    Publication type:
    Article
    32
    33

    Molecular profiling refines minimal residual disease‐based prognostic assessment in adults with Philadelphia chromosome‐negative B‐cell precursor acute lymphoblastic leukemia.

    Published in:
    Genes, Chromosomes & Cancer, 2019, v. 58, n. 11, p. 815, doi. 10.1002/gcc.22788
    By:
    • Ribera, Jordi;
    • Zamora, Lurdes;
    • Morgades, Mireia;
    • Vives, Susana;
    • Granada, Isabel;
    • Montesinos, Pau;
    • Gómez‐Seguí, Inés;
    • Mercadal, Santiago;
    • Guàrdia, Ramon;
    • Nomdedeu, Josep;
    • Pratcorona, Marta;
    • Tormo, Mar;
    • Martínez‐Lopez, Joaquín;
    • Hernández‐Rivas, Jesús‐María;
    • Ciudad, Juana;
    • Orfao, Alberto;
    • González‐Campos, José;
    • Barba, Pere;
    • Escoda, Lourdes;
    • Esteve, Jordi
    Publication type:
    Article
    34

    Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.

    Published in:
    Genes, Chromosomes & Cancer, 2017, v. 56, n. 11, p. 810, doi. 10.1002/gcc.22486
    By:
    • Ribera, Jordi;
    • Zamora, Lurdes;
    • Morgades, Mireia;
    • Mallo, Mar;
    • Solanes, Neus;
    • Batlle, Montserrat;
    • Vives, Susana;
    • Granada, Isabel;
    • Juncà, Jordi;
    • Malinverni, Roberto;
    • Genescà, Eulàlia;
    • Guàrdia, Ramon;
    • Mercadal, Santiago;
    • Escoda, Lourdes;
    • Martinez‐Lopez, Joaquín;
    • Tormo, Mar;
    • Esteve, Jordi;
    • Pratcorona, Marta;
    • Martinez‐Losada, Carmen;
    • Solé, Francesc
    Publication type:
    Article
    35

    Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01298-6
    By:
    • Jimenez-Vicente, Carlos;
    • Cardus, Aina;
    • Castaño-Diez, Sandra;
    • Ramil, Guillermo;
    • Garcia-Avila, Sara;
    • Gomez-Perez, Lucia;
    • Esteban, Daniel;
    • Arribas, Iago;
    • Sturla, Antonella Lucia;
    • Lopez-Guerra, Monica;
    • Martinez-Roca, Alexandra;
    • Cortes-Bullich, Albert;
    • Perez-Valencia, Amanda Isabel;
    • Zugasti, Ines;
    • Monge, Ines;
    • Carcelero, Esther;
    • Vall-Llovera, Ferran;
    • Vives, Susana;
    • Sierra, Jorge;
    • Nomdedeu, Josep
    Publication type:
    Article
    36

    Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
    By:
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Arnan, Montserrat;
    • Pomares, Helena;
    • Alonso, Ester;
    • Tormo, Mar;
    • Diaz-Beya, Marina;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Sampol, Antonia;
    • Coll, Rosa;
    • Salamero, Olga;
    • Cervera, Marta;
    • Garcia, Antoni;
    • Vall-Llovera, Ferran;
    • Garcia-Avila, Sara;
    • Bargay, Joan;
    • Ortin, Xavier;
    • Iranzo, Eva;
    • Guijarro, Francisca
    Publication type:
    Article
    37

    Measurable Residual Disease in UBTF‐TD Adult Acute Myeloid Leukemia.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 6, p. 1052, doi. 10.1111/ejh.14402
    By:
    • Castellet, Helena;
    • Ramil, Guillermo;
    • Carricondo, Maite;
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Artigas, Alícia;
    • Pratcorona, Marta;
    • Salamero, Olga;
    • Cortés‐Bullich, Albert;
    • Vives, Susana;
    • Tormo, Mar;
    • Mascaró, Martí;
    • Gallardo, David;
    • Tutusaus, Josep Maria Marti;
    • Garcia, Antonio;
    • Sierra, Jorge;
    • Esteve, Jordi;
    • Nomdedéu, Josep
    Publication type:
    Article
    38

    Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials.

    Published in:
    European Journal of Haematology, 2019, v. 102, n. 1, p. 79, doi. 10.1111/ejh.13178
    By:
    • Barba, Pere;
    • Morgades, Mireia;
    • Montesinos, Pau;
    • Gil, Cristina;
    • Fox, María‐Laura;
    • Ciudad, Juana;
    • Moreno, María‐José;
    • González‐Campos, José;
    • Genescà, Eulàlia;
    • Martínez‐Carballeira, Daniel;
    • Martino, Rodrigo;
    • Vives, Susana;
    • Guardia, Ramon;
    • Mercadal, Santiago;
    • Artola, María‐Teresa;
    • Cladera, Antonia;
    • Tormo, Mar;
    • Esteve, Jordi;
    • Bergua, Juan;
    • Vall‐Llovera, Ferran
    Publication type:
    Article
    39
    40